- Home
- CPSS vs LYEL Comparison
CPSS vs LYEL Comparison
Compare CPSS & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPSS
- LYEL
- Stock Information
- Founded
- CPSS 1991
- LYEL 2018
- Country
- CPSS United States
- LYEL United States
- Employees
- CPSS N/A
- LYEL N/A
- Industry
- CPSS Finance: Consumer Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- CPSS Finance
- LYEL Health Care
- Exchange
- CPSS Nasdaq
- LYEL Nasdaq
- Market Cap
- CPSS 193.8M
- LYEL 207.7M
- IPO Year
- CPSS 1992
- LYEL 2021
- Fundamental
- Price
- CPSS $9.85
- LYEL $8.69
- Analyst Decision
- CPSS
- LYEL Sell
- Analyst Count
- CPSS 0
- LYEL 2
- Target Price
- CPSS N/A
- LYEL $20.00
- AVG Volume (30 Days)
- CPSS 16.0K
- LYEL 249.1K
- Earning Date
- CPSS 07-29-2025
- LYEL 08-06-2025
- Dividend Yield
- CPSS N/A
- LYEL N/A
- EPS Growth
- CPSS N/A
- LYEL N/A
- EPS
- CPSS 0.79
- LYEL N/A
- Revenue
- CPSS $188,776,000.00
- LYEL $65,000.00
- Revenue This Year
- CPSS $146.82
- LYEL N/A
- Revenue Next Year
- CPSS $18.24
- LYEL N/A
- P/E Ratio
- CPSS $12.38
- LYEL N/A
- Revenue Growth
- CPSS N/A
- LYEL N/A
- 52 Week Low
- CPSS $7.99
- LYEL $7.65
- 52 Week High
- CPSS $12.73
- LYEL $45.42
- Technical
- Relative Strength Index (RSI)
- CPSS 57.64
- LYEL 44.96
- Support Level
- CPSS $9.45
- LYEL $8.96
- Resistance Level
- CPSS $10.17
- LYEL $10.96
- Average True Range (ATR)
- CPSS 0.24
- LYEL 2.14
- MACD
- CPSS 0.01
- LYEL -0.17
- Stochastic Oscillator
- CPSS 70.83
- LYEL 16.91
About CPSS Consumer Portfolio Services Inc.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.